ADVERTISEMENT
Search

Pharmacy News

CDC makes the case for pharmacists’ reimbursement given expanding roles

The health care disruptions created by the public health emergency have revived interest in identifying opportunities to optimize pharmacists’ roles.

FDA expands access to mifepristone to mail-order and community pharmacies

In December 2021, FDA permanently lifted a major restriction on medication abortions that had been temporarily lifted earlier in the COVID-19 pandemic. Prior to the pandemic, patients were required to pick up mifepristone in person from a certified prescriber. In 2020, FDA temporarily lifted this in-person requirement. The new change from FDA will permanently allow any certified mail-order or brick-and-mortar pharmacy to dispense the drug with a prescription.

What strategies do pharmacists use to identify and prevent adverse drug reactions?

In what is believed to be the first study of its kind, researchers examined the cognitive processes health care professionals use to detect, resolve, and monitor adverse drug reactions.

Drug overdose deaths from nonbenzodiazepine sleeping pills and anti-epilepsy gabapentinoids rises

A new study in The Lancet Regional Health Americas found that the proportion of overdose deaths involving nonbenzodiazepine sleeping drugs (also called z-drugs) and anti-epilepsy gabapentinoids increased more than threefold between 2000 and 2018, coinciding with exponential prescription increases since their introduction into the market.

New report shows 82% of patients still experience medication delays

A new report estimates that 82% of patients experienced medication delays in the last year because of COVID-19 restrictions, prescriptions cost, communication challenges, insurance processes, and/or lack of transportation.

RSS
124678910Last